| Laryngeal Verrucous Carcinoma studied in …STUDIED_INderived48 of 48show fewer |
|---|
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473784NA · recruiting Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245100completed Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816984Phase 1/Phase 2 · completed PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177838NA · terminated Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249443Phase 1 · terminated Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192815Phase 2 · terminated Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044433Phase 2 · completed Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469429Phase 1/Phase 2 · completed Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123511Phase 2 · completed Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048020Phase 2 · completed Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164566NA · terminated Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035527Phase 1 · completed Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316757Phase 2 · completed Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068157Phase 2 · terminated Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196168Phase 2 · terminated Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095628Phase 2 · completed SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02007200Phase 2 · completed Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528137Phase 1 · terminated Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114283Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334177Phase 1 · completed TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254734NA · terminated Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507767Phase 2 · completed Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101348Phase 1/Phase 2 · completed Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049283Phase 1 · completed Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103259Phase 2 · completed Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513435Phase 2 · completed Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728480Phase 1 · withdrawn Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00906360Phase 1 · terminated Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155609NA · completed L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674374Phase 2 · withdrawn Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089362Phase 1 · completed Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096512Phase 2 · completed S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033618Phase 2 · completed Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023959Phase 1 · completed Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637194Phase 1 · completed Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 48 trials mapped (2 active) | — | — | Laryngeal Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |